Federal Register / Vol. 89, No. 219 / Wednesday, November 13, 2024 / Notices 89649 

administering FDA regulations 

pertaining to the manufacturing/ 

processing, packing, or holding of food 

for consumption in the United States. 

The Produce Regulatory Program 

Standards (PRPS) are the result of 

external collaboration and coordination 

with the Association of Food and Drug 

Officials (AFDO), the National 

Association of State Departments of 

Agriculture (NASDA), and state produce 

regulatory programs. FDA, NASDA, 

AFDO, and states worked 

collaboratively to develop the content of 

the PRPS. A copy of the standards and 

accompanying worksheets and forms is 

available in the Federal Register docket 

for this notice. We recommend that 

State and Territorial produce safety 

regulatory programs use these program 

standards as the framework to design 

and manage their produce safety 

regulatory programs. The states that 

assisted in the development of PRPS 

were representative of the 43 State and 

Territorial programs regulatory 

programs enrolled currently conducting 

produce safety inspections via funding 

from a cooperative agreement grant, 

‘‘The FDA’s Cooperative Agreement 

Program for States and Territories to 

Implement a National Produce Safety 

Program, PAR–21–174,’’ (this program 

also includes 4 programs which do not 

conduct inspections). For more 

information on this cooperative 

agreement, we invite you to visit our 

website at: https://www.fda.gov/federalstate-local-tribal-and-territorialofficials/grants-and-cooperativeagreements/fda-state-produce-safetyimplementation-cooperative-agreementprogram. 

The PRPS identifies and includes 

resource and training material for the 

following standards: regulatory 

foundations; training; inspection; 

product-specific illnesses, outbreaks 

and hazard response; compliance and 

enforcement; industry and community 

relations; program assessments; and 

product sampling and testing. We 

recommend using the worksheets and 

forms contained in the standards, 

however, alternate forms that are 

equivalent may be used. The 

educational worksheets and resource 

materials include recordkeeping and 

reporting activities that help FDA verify 

participation and successful completion 

of the respective requirements. In the 

first year of enrollment, information is 

used to conduct a baseline selfassessment to determine whether the 

materials meet the elements of each 

standard. In subsequent years, we use 

the information to conduct a 

comprehensive review and evaluate 

program effectiveness and participation. 

We modify the program standards based 

on the ongoing assessments as well as 

comments and informal feedback 

obtained from participants. 

Description of Respondents: 

Respondents are State Departments of 

Agriculture or Health regulatory 

officials who enroll in the PRPS (State 

or Territorial governments). Currently 

we estimate 43 respondents to the 

information collection based on 

expected participation. 

In the Federal Register of June 28, 

2024 (89 FR 54009), FDA published a 

60-day notice requesting public 

comment on the proposed collection of 

information. One comment was received 

that did not pertain to the information 

collection. 

FDA estimates the burden of this 

collection of information as follows: 

TABLE 1—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1

Respondent Number of 

recordkeepers 

Number of 

records per 

recordkeeper 

Total annual 

records 

Average 

burden per 

recordkeeping 

Total hours 

State or Territorial Governments; Maintenance of data 

records consistent with the PRPS ................................... 48 11 528 85.36 45,072 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

Dated: October 30, 2024. 

Kimberlee Trzeciak, 

Deputy Commissioner for Policy, Legislation, 

and International Affairs. 

[FR Doc. 2024–26209 Filed 11–12–24; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Charter Renewal for the Advisory 

Committee on Heritable Disorders in 

Newborns and Children 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Department of Health and Human 

Services is hereby giving notice that the 

Advisory Committee on Heritable 

Disorders in Newborns and Children 

(ACHDNC) charter has been renewed. 

DATES: The effective date of charter 

renewal is November 10, 2024. 

FOR FURTHER INFORMATION CONTACT: 

Leticia Manning, Maternal and Child 

Health Bureau, HRSA, 5600 Fishers 

Lane, 18N38A, Rockville, Maryland 

20857; 301–443–8335; or lmanning@

hrsa.gov. 

SUPPLEMENTARY INFORMATION: ACHDNC 

provides advice and recommendations 

to the Secretary of Health and Human 

Services (Secretary) on the development 

of newborn screening activities, 

technologies, policies, guidelines, and 

programs for effectively reducing 

morbidity and mortality in newborns 

and children having, or at risk for, 

heritable disorders. ACHDNC reviews 

and reports regularly on newborn and 

childhood screening practices, 

recommends improvements in the 

national newborn and childhood 

screening programs, and fulfills 

requirements stated in the authorizing 

legislation. In addition, ACHDNC’s 

recommendations regarding inclusion of 

conditions for screening on the 

Recommended Uniform Screening 

Panel, following adoption by the 

Secretary, are evidence-informed 

preventive health services provided for 

in the comprehensive guidelines 

supported by HRSA pursuant to section 

2713 of the Public Health Service Act 

(42 U.S.C. 300gg–13). Under this 

provision, non-grandfathered group 

health plans and health insurance 

issuers offering non-grandfathered 

group or individual health insurance are 

required to provide insurance coverage 

without cost-sharing (a co-payment, coinsurance, or deductible) for preventive 

services for plan years (i.e., policy years) 

beginning on or after the date that is 1 

year from the Secretary’s adoption of the 

condition for screening. 

The charter renewal for the ACHDNC 

was approved on October 29, 2024. The 

filing date is November 10, 2024. 

Renewal of the ACHDNC charter 


lotter on DSK11XQN23PROD with NOTICES1
89650 Federal Register / Vol. 89, No. 219 / Wednesday, November 13, 2024 / Notices 

authorizes the committee to operate 

until November 10, 2026 

A copy of the ACHDNC charter is 

available on the ACHDNC website at 

https://www.hrsa.gov/advisorycommittees/heritable-disorders/ 

index.html. A copy of the charter also 

can be obtained by accessing the FACA 

database that is maintained by the 

Committee Management Secretariat 

under the General Services 

Administration. The website address for 

the FACA database is http:// 

www.facadatabase.gov/. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2024–26198 Filed 11–12–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Secretary; Notice of 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Science 

Advisory Board for Biosecurity. 

The meeting will be held as a virtual 

meeting and will be open to the public 

as indicated below. Individuals who 

plan to view the virtual meeting and 

need special assistance or other 

reasonable accommodations to view the 

meeting should notify the Contact 

Person listed below in advance of the 

meeting. The meeting will be videocast 

and can be accessed from the NIH 

Videocasting and Podcasting website 

(http://videocast.nih.gov/). 

Name of Committee: National Science 

Advisory Board for Biosecurity. 

Date: November 21, 2024. 

Time: 1:00 p.m. to 2:00 p.m. 

Agenda: The National Science Advisory 

Board for Biosecurity meeting will include a 

review of a new charge to the committee and 

discussion of next steps for the committee. 

Address: National Institutes of Health, 

6705 Rockledge Drive, Suite 630, Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 

Meeting Access: https://osp.od.nih.gov/ 

policies/national-science-advisory-board-forbiosecurity-nsabb#tab3/. 

Contact Person: Cari Young, ScM, Office of 

Science Policy, Office of the Director, 

National Institutes of Health, 6705 Rockledge 

Drive, Suite 630, Bethesda, MD 20892, 301– 

496–9838, SciencePolicy@od.nih.gov. 

This notice is being published less 

than 15 days from the meeting date due 

to exceptional circumstances which did 

not allow sufficient time to submit the 

notice within the typical lead time 

required for publication. The National 

Science Advisory Board for Biosecurity 

meeting will include review of a new 

charge to the committee that, in keeping 

with the committee’s charter, is of vital 

importance to biomedical research, 

public health, and national security. If 

the meeting is not held on November 21, 

2024, committee members and 

participants with the requisite scientific, 

technical, public health, biodefense, and 

national security expertise will be 

unable to participate due to scheduling 

conflicts. Information is also available 

on the Institute’s/Center’s home page: 

https://osp.od.nih.gov/policies/nationalscience-advisory-board-for-biosecuritynsabb#tab3/, where an agenda and any 

additional information for the meeting 

will be posted when available. 

Dated: November 7, 2024. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2024–26268 Filed 11–12–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Acquired 

Immunodeficiency Syndrome Research 

Committee (AIDS) Special Emphasis Panel. 

Date: December 5, 2024. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E71, 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Samita S. Andreansky, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E71, 

Rockville, MD 20892, 240–669–2915, 

samita.andreansky@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: November 6, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–26187 Filed 11–12–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Strategic 

Preparedness and Response 

National Advisory Committee on 

Children and Disasters Public Meeting 

AGENCY: Administration for Strategic 

Preparedness and Response (ASPR), 

U.S. Department of Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The National Advisory 

Committee on Children and Disasters 

(NACCD or the Committee) will conduct 

a public meeting (virtual) to discuss 

potential recommendations to the HHS 

Secretary and ASPR regarding 

challenges, opportunities, and priorities 

for national public health and medical 

preparedness, response, and recovery 

specific to the needs of children and 

their families in disasters. 

DATES: The public meeting (virtual) will 

be held December 4, 2024. 

ADDRESSES: A more detailed agenda and 

meeting registration link will be 

available on the NACCD meeting 

website at https://aspr.hhs.gov/ 

AboutASPR/WorkingwithASPR/ 

BoardsandCommittees/Pages/NACCD/ 

Public-Meetings.aspx. 

FOR FURTHER INFORMATION CONTACT: 

Zhoowan Jackson, NACCD Designated 

Federal Officer, Administration for 

Strategic Preparedness and Response 

(ASPR), U.S. Department of Health and 

Human Services (HHS), Washington, 

DC; 202–205–4217, NACCD@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

NACCD is established by section 2811A 

of the Public Health Service Act (42 

U.S.C. 300hh-10b) as amended by the 

Pandemic and All Hazards Preparedness 

and Advancing Innovation Act and 

governed by the provisions of the 

Federal Advisory Committee Act (5 

U.S.C. app.). The statute directs the 


lotter on DSK11XQN23PROD with NOTICES1